Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

DSpace Repository

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

Author: Harbeck, N.; Schmitt, M.; Meisner, C.; Friedel, C.; Untch, M.; Schmidt, M.; Sweep, C. G. J.; Lisboa, B. W.; Lux, M. P.; Beck, T.; Hasmueller, S.; Kiechle, M.; Jaenicke, F.; Thomssen, C.
Tübinger Autor(en):
Meisner, Christoph
Published in: European Journal of Cancer (2013), Bd. 49, H. 8, S. 1825-1835
Verlagsangabe: Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.ejca.2013.01.007
ISSN: 0959-8049
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)